Gastroenterology

Dive into EMJ Gastroenterology now, to explore an array of peer-reviewed articles, exclusive interviews with leading experts in the…

This poster review article summarised selected original research covering recent advances in the management of various gastrointestinal diseases, including inflammatory bowel disease, disorders of gut–brain interactions, gastro-oesophageal reflux disease, and pancreatic disorders, presented at the United European Gastroenterology (UEG) Week, which took place in Vienna, Austria, between 8th–11th October 2022.

This mini-review is the fourth in a series exploring TNF inhibitors in treating immune-mediated inflammatory disease. Specifically, this mini-review summarises the evidence of anti-TNFs in Crohn’s disease (CD) complicated by intra-abdominal abscess.

Welcome to the latest issue of EMJ Gastroenterology, which outlines key advances in the field. Featured articles include a case report on medullary carcinoma of the pancreas and a review of the challenges in inflammatory bowel disease management during the COVID-19 pandemic in resource-limited settings. Our independent review of United European Gastroenterology (UEG) Week 2022 is also not to be missed!

This mini case study review article is the third in a series exploring tumour necrosis factor (TNF) inhibitors in the treatment of immune-mediated disease. This article explores anti-TNF therapies, which are generally considered to be an effective, well-tolerated treatment option for the management of chronic conditions related to the overproduction of TNF-α.

The 2022 International Scientific Conference of Probiotics, Prebiotics, Gut Microbiota and Health® took place in Bratislava, Slovakia, from 27th–30th June. A common theme throughout the conference was that, although significant progress has been made, considerable work remains to be done in understanding how probiotics work, aligning definitions of microbiome-modifying agents, and communicating evidence-based recommendations to clinicians and consumers.

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

Digestive Disease Week (DDW) 2022 was held both in San Diego, California, USA, and virtually. The meeting featured cutting-edge research and education in the field of gastroenterology, of which eight treatment-related presentations are summarised in this article. Two presentations covered recent patient surveys.